May 5, 2025 - 03:29

Jill Bruning has emerged as a significant figure in the technology landscape as the Chief Technology Officer of Amentum. The company, recently launched as a global public entity with a valuation of $13.9 billion, employs around 53,000 individuals and is poised for substantial growth in the coming years. Bruning's leadership in this role is crucial as she navigates the complexities of technology integration and innovation within the organization.
With a robust background in engineering and technology management, Bruning is dedicated to driving Amentum's mission forward. She emphasizes the importance of leveraging advanced technologies to enhance operational efficiency and deliver innovative solutions to clients. Her strategic vision focuses on fostering a culture of collaboration and continuous improvement among her team, ensuring that Amentum remains at the forefront of technological advancements.
As the industry evolves, Bruning's insights and initiatives will likely play a pivotal role in shaping the future of Amentum and its impact on the global market. Her commitment to excellence and innovation positions her as a leader to watch in the technology sector.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...